Pulmonx Corporation (LUNG) Tops Q4 EPS by 12c
Tweet
Share
E-mailGet Alerts LUNG Hot Sheet
Join SI Premium – FREE
Pulmonx Corporation (NASDAQ: LUNG) reported Q4 EPS of ($0.33), $0.12 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $23.8 million versus the consensus estimate of $22.29 million.
For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Lilly breaks ground on $6.5B Houston drug manufacturing site
- Woodward to shift California aerospace output to South Carolina
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
